Business Description
Scopus BioPharma Inc
NAICS : 325412
SIC : 2834
ISIN : US8091711015
Description
Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system. The endocannabinoid system is comprised of chemical compounds, or cannabinoids, that interact with cannabinoid receptors which are located throughout the body. Its product candidate comprises CO-sTiRNA, which is a STAT3 inhibitor gene therapy and MRI-1867.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 28.47 | |||||
9-Day RSI | 36.69 | |||||
14-Day RSI | 40.59 | |||||
12-1 Month Momentum % | 33.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-FCF | -0.01 | |||||
FCF Yield % | -12172 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SCPS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Scopus BioPharma Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.32 | ||
| Beta | 29.4316 | ||
| 3-Year Sharpe Ratio | -0.03 | ||
| 3-Year Sortino Ratio | -0.05 | ||
| Volatility % | 131.11 | ||
| 14-Day RSI | 40.59 | ||
| 14-Day ATR ($) | 0.000025 | ||
| 20-Day SMA ($) | 0.00044 | ||
| 12-1 Month Momentum % | 33.33 | ||
| 52-Week Range ($) | 0.0003 - 0.01 | ||
| Shares Outstanding (Mil) | 42.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Scopus BioPharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Scopus BioPharma Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 141 days | ||
| Second quarter earnings results for 2026 | 2026-07-20 | In 25 days | ||
| General meeting for 2025 | 2026-07-14 | In 19 days | ||
| Annual report for 2025 | 2026-06-23 | 0.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-06-23 | 0.00 (+0.00%) |
Show
Entries
Scopus BioPharma Inc Frequently Asked Questions
What is Scopus BioPharma Inc(SCPS)'s stock price today?
The current price of SCPS is $0.00. The 52 week high of SCPS is $0.01 and 52 week low is $0.00.
When is next earnings date of Scopus BioPharma Inc(SCPS)?
The next earnings date of Scopus BioPharma Inc(SCPS) is 2026-06-30 Est..
Does Scopus BioPharma Inc(SCPS) pay dividends? If so, how much?
Scopus BioPharma Inc(SCPS) does not pay dividend.
Guru Commentaries on OTCPK:SCPS
No articles.
Press Release
Articles on Scopus BioPharma Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers